BCPC logo

Balchem Corporation Stock Price

NasdaqGS:BCPC Community·US$4.7b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

BCPC Share Price Performance

US$144.64
-27.73 (-16.09%)
27.8% undervalued intrinsic discount
US$200.33
Fair Value
US$144.64
-27.73 (-16.09%)
27.7% undervalued intrinsic discount
US$200.03
Fair Value
Price US$144.64
AnalystConsensusTarget US$200.03

BCPC Community Narratives

AnalystConsensusTarget·
Fair Value US$200.33 28.9% undervalued intrinsic discount

New York Facility And European Policies Will Reshape Nutrition Sectors

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative

Balchem Corporation Key Details

US$985.9m

Revenue

US$633.0m

Cost of Revenue

US$353.0m

Gross Profit

US$210.2m

Other Expenses

US$142.8m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Oct 21, 2025
Earnings per share (EPS)
4.40
Gross Margin
35.80%
Net Profit Margin
14.48%
Debt/Equity Ratio
15.0%

Balchem Corporation Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Flawless balance sheet with solid track record.

0 Risks
4 Rewards

About BCPC

Founded
1967
Employees
1364
CEO
Theodore Harris
WebsiteView website
www.balchem.com

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.

Market Insight

Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading

U.S. Market Performance

  • 7 Days: -2.7%
  • 3 Months: 5.1%
  • 1 Year: 13.4%
  • Year to Date: 11.7%
Over the last 7 days, the market has dropped 2.7%, driven by a loss of 2.5% in the Information Technology sector. As for the longer term, the market has actually risen by 13% in the last year. As for the next few years, earnings are expected to grow by 15% per annum. Market details ›